Cadila Healthcare in focus after USFDA approval

Image
Capital Market
Last Updated : Nov 18 2019 | 9:04 AM IST

Shares of Cadila Healthcare will be in focus. Zydus Cadila has received the tentative approval from the USFDA to market Apremilast Tablets (US RLD Otezla) 10 mg, 20 mg, and 30 mg. This medication is used to treat a certain type of arthritis (psoriatic arthritis) and a certain type of skin condition (moderate to severe plaque psoriasis). t is also used to treat mouth sores in people who have Behcet's disease, a type of inflammatory disorder and helps to reduce the pain and improve the healing of these mouth sores.

Unichem Laboratories announced that it has received ANDA approval for its Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg, and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bristol-Myers Squibb Company (BMS), Buspar Tablets, 5 mg, 10 mg, 15 mg, and 30 mg.

Tata Motors said that the board approved committee has approved allotment of 5000 Rated, Listed, Unsecured, Redeemable, Non-Convertible Debentures (NCDs) E28-A Series of face value Rs 10 lakh each, at par, aggregating to Rs 500 crore in three tranches, on private placement basis.

Hinduja Global Solutions said that Hinduja Global Solutions UK, a subsidiary of the company which holds 57% equity interest in Element Solutions LLC, USA has, acquired an additional 14.33% equity interest in the Element Solutions LLC, USA in accordance with the purchase agreement entered on 29 March 2018.

HIL said the company has added additional capacities and commenced the production of its CpVC, UpVC and 'SWR (Soil, Waste & Rain) Pipes at its plant located at Thimmapur, Telangana.

Asian Oilfield Services has entered into a Share Purchase Agreement dated 15 November 2019 for acquisition of 51% of equity share capital of Optimum Oil & Gas from its existing shareholder. The company currently holds 23% of equity share capital of Optimum. On completion of all closing formalities, Optimum will become a subsidiary of the company with 74% holding.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 18 2019 | 8:29 AM IST

Next Story